Market Cap

Tilray, Inc. Market Capitalization:

$1.13 Billion

USD as of Jan. 1, 2026

business Tilray, Inc. Company Profile

Tilray, Inc. Main Stock Listing

NASDAQ: TLRY

Market Capitalization History of Tilray, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Tilray, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.13 B 7.79%
Jan. 1, 2025 $1.05 B -37.99%
Jan. 1, 2024 $1.69 B -1.11%
Jan. 1, 2023 $1.71 B -50.39%
Jan. 1, 2022 $3.44 B -67.07%
Jan. 1, 2021 $10.44 B 3.19%
Jan. 1, 2020 $10.12 B -78.21%
Jan. 1, 2019 $46.43 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Tilray, Inc. Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

Tilray, Inc. has the following listings and related stock indices.


Stock: NASDAQ: TLRY

Stock: FSX: 2HQ

Stock: TSX: TLRY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.